3 years since last CLABSI in ICU, reports New York hospital

NYC Health + Hospitals/Queens hasn’t reported any central line-associated bloodstream infections among intensive care unit patients for three consecutive years, the New York City-based hospital said Dec. 7. 

Advertisement

The hospital credits the success to a multilayered infection prevention approach. NYC Health + Hospitals/Queens has implemented new technologies to reduce its reliance on central lines, performs daily reviews of central line necessity and uses central line bundles of care, among other efforts. 

Patients who develop CLABSIs are subject to longer hospital stays, high hospital costs and a higher risk of death, according to Jean Fleischman, MD, a pulmonary critical care attending physician who also serves as the hospital’s associate director of medicine and deputy medical director for quality assurance and performance improvement. 

“I am delighted that NYC Health + Hospitals/Queens has reached this milestone of being CLABSI-free for three full years, particularly during a period where we weathered the hardships accelerated by the coronavirus pandemic,” Dr. Fleischman said in a news release.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Infection Control

Advertisement

Comments are closed.